Cormorant Asset Management, LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2021$400,000
-41.2%
20,000
-50.0%
0.01%
-43.8%
Q4 2020$680,000
-18.1%
40,000
-20.0%
0.02%
-50.0%
Q3 2020$830,000
-71.3%
50,000
-60.0%
0.03%
-70.9%
Q2 2020$2,895,000
+8.1%
125,000
-16.7%
0.11%
-11.3%
Q1 2020$2,678,000
-38.0%
150,000
-25.0%
0.12%
-27.9%
Q4 2019$4,317,000
-70.0%
200,000
-74.6%
0.17%
-80.3%
Q3 2019$14,368,000
+1.0%
788,800
+97.2%
0.88%
+7.1%
Q2 2019$14,232,000
-15.3%
400,000
-20.0%
0.82%
-28.0%
Q1 2019$16,800,000
-35.9%
500,000
-37.3%
1.14%
-46.6%
Q4 2018$26,198,000
-84.1%
797,000
-70.5%
2.13%
-80.1%
Q3 2018$164,494,000
+1.2%
2,698,400
-18.9%
10.69%
-11.1%
Q2 2018$162,526,000
-62.6%
3,328,400
-18.7%
12.03%
-62.9%
Q1 2018$435,039,000
+165.1%
4,094,100
+49.0%
32.43%
+88.8%
Q4 2017$164,093,000
+470.0%
2,747,700
+35.8%
17.18%
+320.8%
Q2 2016$28,786,000
+4.7%
2,022,879
+1.1%
4.08%
-1.5%
Q1 2016$27,500,000
+113.3%
2,000,000
+161.4%
4.14%
+168.7%
Q4 2015$12,893,000
+195.9%
765,156
+92.5%
1.54%
+121.6%
Q3 2015$4,357,000
-12.4%
397,5000.0%0.70%
+5.3%
Q2 2015$4,973,000
+13.7%
397,5000.0%0.66%
-2.2%
Q1 2015$4,373,000
-37.3%
397,500
-11.7%
0.68%
-37.2%
Q4 2014$6,975,000
+28.4%
450,0000.0%1.08%
-3.7%
Q3 2014$5,432,000450,0001.12%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders